GGZinGeest
- Address
- Amstelveenseweg 589, 1081 JC Amsterdam, The Netherlands
GGZinGeest - Specialized Psychiatric Treatment Research Center
GGZinGeest is a leading psychiatric research institution dedicated to advancing treatment options for severe and treatment-resistant mental health conditions. The center focuses on innovative therapeutic approaches for patients who have not responded to conventional treatments, conducting rigorous clinical trials to evaluate novel interventions and comparative effectiveness studies.
- Treatment-resistant depression and advanced therapeutic interventions including oral esketamine and electroconvulsive therapy
- Catatonia in psychiatric disorders including depression, bipolar disorder, and psychotic conditions
- Novel pharmacological treatments for severe psychiatric syndromes
The center's research portfolio demonstrates expertise in managing complex psychiatric presentations, particularly focusing on non-psychotic therapy resistant unipolar depression and catatonia. Through randomized controlled trials, GGZinGeest evaluates both acute treatment efficacy and long-term maintenance strategies, comparing emerging treatments like oral esketamine and sodium oxybate against established interventions such as electroconvulsive therapy. This comprehensive approach to psychiatric research positions the center at the forefront of developing evidence-based solutions for patients with the most challenging mental health conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Amsterdam UMC Stichting1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in GGZinGeest
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy of Oral Esketamine Versus Electroconvulsive Therapy in Non-Psychotic Treatment-Resistant Unipolar Depression | Universitair Medisch Centrum Groningen | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Esketamine | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.